Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Farmers Insurance
US Army
Julphar
McKinsey
Medtronic
UBS
Covington
Accenture

Generated: February 23, 2018

DrugPatentWatch Database Preview

POLYCILLIN Drug Profile

« Back to Dashboard

When do Polycillin patents expire, and what generic alternatives are available?

Polycillin is a drug marketed by Bristol and Apothecon and is included in seven NDAs.

The generic ingredient in POLYCILLIN is ampicillin/ampicillin trihydrate; probenecid. Additional details are available on the ampicillin/ampicillin trihydrate; probenecid profile page.

US Patents and Regulatory Information for POLYCILLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol POLYCILLIN ampicillin/ampicillin trihydrate CAPSULE;ORAL 050310-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 050308-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon POLYCILLIN ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 062297-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 050308-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN-PRB ampicillin/ampicillin trihydrate; probenecid FOR SUSPENSION;ORAL 050457-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN ampicillin/ampicillin trihydrate CAPSULE;ORAL 050310-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon POLYCILLIN ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 062297-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol POLYCILLIN ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 050308-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
QuintilesIMS
Cantor Fitzgerald
UBS
Medtronic
Fish and Richardson
Merck
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot